ConductScience.org, home

Paper345313

A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.

Falloon I and 2 others. Psychol Med, 1978. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Papers, record 345313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/345313

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
PubMed
Journal
Psychol Med
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
8.67
iCite
Revised in PubMed
2019-08-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Falloon II
2Watt DCD C
3Shepherd MM

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FluphenazineMajor topic
PimozideMajor topic
SchizophreniaMajor topic
Adult
Clinical Trials as Topic
Depression
Female
Humans
Male
Recurrence

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
33628500Depression among Patients with Schizophrenia in Ethiopian Mental Health Hospital: Association with Sociodemographic and Clinical Variables: A Cross-Sectional Study.Depress Res Treat2021https://conductscience.org/library/papers/33628500PubMed
25654768Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/25654768PubMed
24194433Pimozide for schizophrenia or related psychoses.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/24194433PubMed
23256986Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.Schizophr Bull2014https://conductscience.org/library/papers/23256986PubMed
22058545Fluphenazine decanoate in chronic schizophrenia.Indian J Psychiatry1981https://conductscience.org/library/papers/22058545PubMed
20919315Is an oral neuroleptic suitable for continuing drug treatment in schizophrenia?Proc R Soc Med1977https://conductscience.org/library/papers/20919315PubMed
15224101A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.Mol Psychiatry2004https://conductscience.org/library/papers/15224101PubMed
15175112A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia.Ann Gen Hosp Psychiatry2004https://conductscience.org/library/papers/15175112PubMed
12600227Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.Drugs2003https://conductscience.org/library/papers/12600227PubMed
11835695Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).BMC Psychiatry2001https://conductscience.org/library/papers/11835695PubMed
8218426Post-psychotic depression in schizophrenia.Eur Arch Psychiatry Clin Neurosci1993https://conductscience.org/library/papers/8218426PubMed
7917075Long-term depot antipsychotics. A risk-benefit assessment.Drug Saf1994https://conductscience.org/library/papers/7917075PubMed
7520856Depot antipsychotic drugs. Place in therapy.Drugs1994https://conductscience.org/library/papers/7520856PubMed
6805002Pimozide in the treatment of newly admitted schizophrenic patients.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6805002PubMed
6356386Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.Soc Psychiatry1983https://conductscience.org/library/papers/6356386PubMed
6111332Assessment of anti-psychotic drugs.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6111332PubMed
3976953Psychiatric epidemiology and epidemiological psychiatry.Am J Public Health1985https://conductscience.org/library/papers/3976953PubMed
3803397Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study.Eur Arch Psychiatry Neurol Sci1986https://conductscience.org/library/papers/3803397PubMed
3140934Psychiatric morbidity of a long stay hospital population with chronic schizophrenia and implications for future community care.BMJ1988https://conductscience.org/library/papers/3140934PubMed
2395175Treatment compliance and hostility levels of head-injured psychiatric outpatients.J Natl Med Assoc1990https://conductscience.org/library/papers/2395175PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/345313

GET https://conductscience.org/api/papers/v1/345313/cited_by?page=2